Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001754429-25-000003
Filing Date
2025-01-14
Accepted
2025-01-14 10:08:26
Documents
1
Period of Report
2025-01-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 2944
  Complete submission text file 0001754429-25-000003.txt   4727
Mailing Address 189 WELLS AVE NEWTON MA 02459
Business Address
CONAWAY DALE H (Reporting) CIK: 0001261770 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35027 | Film No.: 25528023

Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Issuer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)